Zynesp (darbepoetin alfa biosimilar)
/ Zydus Lifesci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 10, 2020
DREAM-ND: Desidustat in the Treatment of Anemia in CKD
(clinicaltrials.gov)
- P3; N=588; Recruiting; Sponsor: Cadila Healthcare Limited; Trial completion date: Dec 2020 ➔ Dec 2021; Trial primary completion date: Aug 2020 ➔ Sep 2021
Clinical • Trial completion date • Trial primary completion date • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
August 28, 2019
DREAM-ND: Desidustat in the Treatment of Anemia in CKD
(clinicaltrials.gov)
- P3; N=588; Recruiting; Sponsor: Cadila Healthcare Limited; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open
July 09, 2019
DREAM-ND: Desidustat in the Treatment of Anemia in CKD
(clinicaltrials.gov)
- P3; N=588; Not yet recruiting; Sponsor: Cadila Healthcare Limited
Clinical • New P3 trial
1 to 3
Of
3
Go to page
1